On September 30, 2021 BYOMass, Inc., a biotech company developing selective TGF-β superfamily therapeutics, reported that it will be participating in the BIO-Europe Digital 2021 Conference, taking place virtually October 25 to 28 (Press release, BYOMass, SEP 30, 2021, View Source [SID1234592175]). Members of the BYOMass business development team will participate in partnering activities at this conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To schedule a meeting, please use the BIO-Europe partnering portal or contact us.

The international BIO-Europe 2021 gathering will be held digitally to bring the global biopharma and investment leaders together to build partnerships that facilitate innovation and medical breakthroughs with four days of presentations and productive one-on-one partnering meetings.